Initial_staging_of_non-small_cell_lung_cancer:_value_of_routine_radioisotope_bone_scanning._The_exclusion_of_bone_metastases_is_important_in_the_initial_staging_of_non-small_cell_lung_cancer,_though_there_is_debate_about_whether_bone_scans_should_be_performed_routinely_or_restricted_to_patients_who_present_with_clinical_or_laboratory_indicators_suggesting_skeletal_metastases._In_a_prospective_study_of_110_consecutive_patients_referred_for_initial_staging_of_non-small_cell_lung_cancer,_we_assessed_the_sensitivity_of_a_group_of_clinical_indicators_(chest_pain,_skeletal_pain,_bone_tenderness_on_physical_examination,_serum_alkaline_phosphatase,_and_serum_calcium)_for_the_presence_of_skeletal_metastases_as_determined_by_bone_scanning._The_final_staging_result_was_validated_with_follow_up_data_over_at_least_three_years._At_the_initial_staging_37_of_110_bone_scans_(34%)_showed_areas_of_increased_uptake,_of_which_only_nine_were_confirmed_to_be_metastases_(by_tomography,_computed_tomography,_or_biopsy)._Half_the_patients_(55)_had_at_least_one_clinical_indicator_suggesting_skeletal_metastases,_including_all_patients_with_proved_skeletal_metastases._Thus_the_sensitivity_of_these_clinical_indicators_was_100%_and_the_specificity_54%._Within_one_year_three_of_27_patients_with_non-confirmed_positive_bone_scans_had_skeletal_metastases,_one_of_which_was_in_the_area_that_had_shown_increased_uptake_initially._All_these_patients_had_clinical_indicators_for_skeletal_metastases_and_all_had_inoperable_advanced_tumours._Four_of_69_patients_with_an_initially_negative_bone_scan_developed_skeletal_metastases_within_one_year._It_is_concluded_that_in_non-small_cell_lung_cancer_bone_scanning_can_be_restricted_to_patients_with_clinical_indicators_for_skeletal_metastases._This_approach_reduces_the_number_of_bone_scans_and_consecutive_investigations_without_loss_of_sensitivity_in_the_detection_of_skeletal_metastases.